Caligan Partners将支持以每股至少3美元的价格出售该公司。潜在的购买方可能包括CSL Behring(OTCPK:CSLY)、Grifols(纳斯达克:GRFS)、武田夏尔和Octaharma。私募股权机构也可能对公司感兴趣。
查看全文
智通财经APP了解到,低价股虽然波动很大,但可能成为投资组合中有吸引力的补充部分。 尽管今年美股大幅下滑,但一些低价生物科技股实现了三位数涨幅。具体如下: ADMA Biologics 对ADMA Biologics(ADMA.US)来说,今年是丰收的一年,其股... 网页链接
$ADMA Biologics Inc(ADMA)$ 8-K - Current report Filed: 2017-02-17 AccNo: 0001193805-17-000287 Size: 31 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$ADMA Biologics Inc(ADMA)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-14 AccNo: 0001019056-17-000202 Size: 110 KB 网页链接
$ADMA Biologics Inc(ADMA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-13 AccNo: 0001085146-17-000619 Size: 57 KB 网页链接
$ADMA Biologics Inc(ADMA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-13 AccNo: 0000919574-17-001309 Size: 119 KB 网页链接
$ADMA Biologics Inc(ADMA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-01-30 AccNo: 0001193125-17-023341 Size: 161 KB 网页链接
$ADMA Biologics Inc(ADMA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-01-25 AccNo: 0000950142-17-000154 Size: 284 KB 网页链接
$ADMA Biologics Inc(ADMA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-01-24 AccNo: 0000950142-17-000152 Size: 216 KB 网页链接
$ADMA Biologics Inc(ADMA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-01-24 AccNo: 0000950142-17-000151 Size: 334 KB 网页链接
$ADMA Biologics Inc(ADMA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-01-25 AccNo: 0000950142-17-000154 Size: 284 KB 网页链接
$ADMA Biologics Inc(ADMA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-01-24 AccNo: 0000950142-17-000152 Size: 216 KB 网页链接